Lung Cancer Surgery and Transplantation:

Even after careful selection, considering the stage, location and cell type of the cancer, the operative death rate of lung cancer surgery is about 4.4%. Hence surgery is only suitable for NSCLC stages 1A, 1B, 2A and 2B. In thoracotomy, the surgeon generally opens up the chest cavity by making an incision in the side of the chest and by spreading apart the ribs to gain access to the cancerous tissues.

A lung transplant expels an individual's diseased lung and replaces it with a healthy one. The healthy lung originates from a benefactor who has died. Lung transplants are utilized for individuals who are probably going to die from lung diseases within 1 to 2 years. Their conditions are severe to different medications, for example, drugs or breathing gadgets, no longer work. Lung transplants regularly are utilized to treat individuals who have serious COPD, Cystic fibrosis, Idiopathic pulmonary fibrosis, Alpha-1 antitrypsin inadequacy and pulmonary hypertension.

    Related Conference of Lung Cancer Surgery and Transplantation:

    December 17-18, 2025

    13th International Conference on Catalysis and Chemical Engineering

    Aix-en-Provence, France
    January 22-23, 2026

    26th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    February 25-26, 2026

    16th International Conference on Chemistry Meeting

    Paris, France
    February 26-27, 2026

    29th World Congress on Materials Chemistry

    Paris, France
    June 17-18, 2026

    15th World Congress on Chromatography

    Paris, France
    September 21-22, 2026

    16th International Chemistry Congress

    Barcelona, Spain

    Lung Cancer Surgery and Transplantation: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in